Ariad Pharmaceuticals Inc. (ARIA) Stock News, Earnings & History

(NASDAQ:ARIA) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 25.40
52wk low: 15.13
EPS: -1.36
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 3.40B
Avg Vol (3m): 3.09M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERGER HARVEY J M D Chairman & CEO Apr 17 Sale 18.01 100,000 1,800,590 1,667,521 Apr 22 05:07 PM
BERGER HARVEY J M D Chairman & CEO Apr 17 Sale 18.00 5,400 97,201 22,057 Apr 22 05:07 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Apr 02 Sale 18.05 2,400 43,322 208,898 Apr 03 04:47 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Apr 02 Sale 18.05 2,400 43,327 117,871 Apr 03 04:47 PM
FITZGERALD EDWARD M Executive VP, CFO Apr 02 Sale 18.04 5,200 93,813 199,355 Apr 03 04:50 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Apr 02 Sale 18.04 2,400 43,295 57,682 Apr 03 04:52 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 02 Sale 18.04 6,500 117,245 363,705 Apr 03 04:53 PM
Cantor Maria E SVP, Corporate Affairs Apr 02 Sale 18.04 4,250 76,665 62,275 Apr 03 04:55 PM
Haluska Frank SVP, Clinical R&D, CMO Apr 02 Sale 18.04 3,400 61,339 73,907 Apr 03 04:57 PM
Keane Raymond T SVP General Counsel & CCO Apr 02 Sale 18.05 2,583 46,625 54,096 Apr 03 04:58 PM
Yahoo, HV, Market Watch, The Wall St. Journal